It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and overdose associated with opioids.
( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults.
If you struggle with lower back pain, you may want to consider ‘striking a pose’–with yoga, that is. A study found those who took an online yoga class once a week for 12 weeks noticed a difference ...